Skip to main content

Drs. Beier and Head Lead New Grant to Study Origin of AD Pathology

By Carousel Slider, In the News
Kevin Beier, PhD, Assistant Professor, Physiology & Biophysics School of Medicine Drs. Kevin Beier and Elizabeth Head, both faculty members of UCI MIND, along with co-investigators Drs. Liz Chrastil and Jing Zhang have been awarded a 4 year NIH grant to study how hyperexcitability in neurons in a unique brain region (the retrospenial cortex thought to be a candidate site where AD pathology begins) contributes to the development of behavioral deficits in 3 mouse models of AD and what the molecular mechanisms are that underlie this effect. To translate their results to AD in people, they will assess the molecular…
Read More

Experts vary in responses to learning Alzheimer’s genetic risk

By Carousel Slider, In the News
This week NPR published an article describing the reactions of three scientists who learned and subsequently shared their APOE genetic results.  What makes this story unique is the way these highly informed people responded to learning their results and their convergent paths of using this knowledge to help advance Alzheimer’s research. The three scientists discovered at various points in their life that they were homozygous for the e4 allele of the apolipoprotein E (APOE) gene. APOE codes for a protein that functions primarily to move cholesterol around the body.   The e4 allele of the APOE gene is also the strongest…
Read More

Honoring the Gift of Brain Donation: A Resource Website for Staff and Researchers

By Carousel Slider, In the News
Lourdes Gonzalez holding a tissue sample (photo by Steve Zylius) Postmortem neuropathological examination of brain tissue is considered the gold standard for understanding many neurological diseases, including Alzheimer’s disease and related dementias (ADRD). Although fluid and imaging biomarkers provide scientists and clinicians with valuable insights into the diseases of the brain, these measures are standardized with brain autopsy to give researchers direct evidence needed to confirm diagnoses, study disease processes, and develop future treatments. Neuropathological examination can only be made through the generous gift of brain donation. A new resource website is being launched for brain tissue repositories to help…
Read More

Dr. Swarup Awarded Alzheimer’s Association Grant

By Carousel Slider, In the News
Dr. Vivek Swarup has been awarded an Alzheimer's Association Research Grant to study oligodendrocyte dysfunction in Alzheimer’s disease (AD). Dr. Swarup writes that Alzheimer’s disease has long been thought of as a problem of nerve cells, but new evidence shows that support cells called oligodendrocytes (OLs) may also play a direct role in driving the disease. These cells help insulate and protect nerves, but in Alzheimer’s, they appear to malfunction and may even produce harmful amyloid plaques. Our project will test how changes in a key regulator of OL affect its function and Alzheimer’s progression. By targeting OL dysfunction, we…
Read More

Dr. Karen Lincoln Appointed Co-Chair of New State Council on Toxic Substance Control

By Carousel Slider, In the News
The Department of Toxic Substances Control (DTSC) has appointed Dr. Karen Lincoln, a faculty member at UCI MIND, as a co-chair of its Environmental Justice Advisory Council (EJAC). This council is dedicated to protecting California communities that face disproportionate exposure to toxic substances. To read more about Dr. Lincoln’s appointment, click here.
Read More

UCI MIND researchers identify natural compounds to remove harmful proteins associated with Alzheimer’s disease

By Carousel Slider, In the News
UCI News highlighted a newly published study by Drs. Ricardo Santana (pictured left) and Gregory Brewer (pictured right)in the journal, GeroScience, in which they identified a combination of natural compounds that clear away harmful proteins associated with Alzheimer's disease. To read the UCI news article, click here.
Read More

UCI MIND Investigators Featured in UCI News for New Study on Sex Differences in AD Pathology Among Individuals with Down Syndrome

By Carousel Slider, In the News
Left to right: Elizabeth Andrews and Dr. Elizabeth Head UCI News highlighted a newly published study in Alzheimer's and Dementia led by Elizabeth Andrews, a PhD candidate in Dr. Elizabeth Head’s Lab, showing that women with Down syndrome may develop Alzheimer's disease more rapidly than men. To read the UCI news article, click here.
Read More

UCI MIND Trainees Recognized for Scientific Impact at AAIC

By Carousel Slider, In the News
At the recent Alzheimer’s Association International Conference (AAIC), thousands of posters were presented by investigators from around the world. The Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment (ISTAART) is a network of scientists, clinicians and dementia professionals who maintain Professional Interest Areas (PIAs). At AAIC, the leadership of the various PIAs selected trainees’ (graduate students and post-docs) poster for a competition in which the evaluation criteria was scientific impact. Remarkably, 3 UCI MIND trainees were selected. Paul Gaona-Partida (mentor Daniel Gillen) was selected for the Diversity and Disparities PIA for his poster “Assessing syndromic diagnosis and amyloid…
Read More

Dr. Lisi Flores-Aguilar wins the Postdoctoral Best Poster Award at AAIC

By Carousel Slider, In the News
Lisi Flores-Aguilar, PhD, a postdoctoral scholar in the Head Lab, was awarded with the Postdoctoral Best Poster Award for the Down Syndrome and Alzheimer's Disease Professional Interest Area (PIA) at this year's Alzheimer’s Association International Conference (AAIC). Her poster "Resilience to Alzheimer's disease in individuals with Down Syndrome” conveyed novel findings of her research. As a postdoctoral fellow in the lab of  Dr. Elizabeth Head, Dr. Lisi Flores-Aguilar studies cerebrovascular contributions to Alzheimer's diseases in individuals with Down syndrome using digital pathology.
Read More